CADDA Annual Conference Manchester

Join us in Manchester for the Centre for Advanced Diagnostic Development and Application (CADDA) Annual Conference, 15th September 2026 - Manchester Institute of Biotechnology
We have designed a stimulating meeting programme with exceptional industrial/academic speakers covering the entire spectrum of diagnostics – from development to application and adoption to PoC. As well as short presentations from our exemplar projects, we will provide updates on our CKTV funded projects. Throughout the day there will also be a focussed workshop and a topical panel session covering new and exciting developments and challenges in the diagnostic field.

Built for networking, this meeting is a great chance to connect and showcase your work. We encourage you to present a poster—there will be a poster prize, and a number of bursaries are available for Early Career Researchers*. So please share this with any ECRs colleagues who might not be members of CADDA but would benefit from attending the conference.

Sessions include:

Session 1 - Current big areas of diagnostics

Session 2 - Working models and scenarios

Session 3 - Translational from idea to diagnostic product

Info: • Siddarth Banka (University of Manchester)
• Al Edwards (University of Southampton)
Workshop session

Info: KEYNOTE - Bill Newman (University of Manchester)
Exemplar #1 Jacqui Matthews (Austin Davis Biologics Ltd) & University of Kent
Exemplar #2 - Matt Gibson (University of Manchestera) & Iceni Glycoscience
Exemplar #3 - Prof Sumeet Mahajan (Brainalyze) & Tushar Jhanwar (University of Kent)
Worskshop session

Info: CKTV funded projects updates.
• Solving the non-specific binding challenge for glycan binding reagents to accelerate next generation lateral flow diagnostics (University of Manchester & Global Access Diagnostics)
• The Development of Cellulose-Binding Protein (CBP) Fusions for Use in Rapid Diagnostics (University of Kent & Austin Davis)
• Salt-driven Power-free Electrokinetic Enhancement of Lateral Flow Assay Sensitivity for Malaria and HIV Diagnostics (UCL & Global Access Diagnostics)
• Engineered CYP2C19 Cell Lines for point-of-care test (POCT) quality assessment (7University of Manchester & EMQN)
• A risk prediction score for Alzheimer’s disease in symptomatic and asymptomatic individuals using a novel array of single nucleotide polymorphisms (University of Manchester & StrataStem)
• Kent and Medway Brain Health Clinic: A pilot study of streamlined dementia assessment using blood biomarkers, low-field MRI and electronic cognitive testing (University of Kent & Hyperfine)

Chaire

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher CADDA